Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-21-000045
Filing Date
2021-11-04
Accepted
2021-11-04 19:03:41
Documents
1
Period of Report
2021-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163606700536434.html 4  
1 FORM 4 wf-form4_163606700536434.xml 4 5795
  Complete submission text file 0001819790-21-000045.txt   7166
Mailing Address 233 WILSHIRE BOULEVARD SUITE 280 SANTA MONICA CA 90401
Business Address
Mottiwala Aziz (Reporting) CIK: 0001788542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 211381703

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)